ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000265443.1	Ponatinib	Pancreatic adenocarcinoma	0.01580157	Resistant
ENSG00000265443.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.042880273	Sensitive